Skip to main content

and
  1. Article

    Open Access

    Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis

    During apoptosis, mitochondrial outer membrane permeabilization (MOMP) enables certain mitochondrial matrix macromolecules to escape into the cytosol. However, the fate of mitochondrial RNA (mtRNA) during apop...

    Shane T. Killarney, Rachel Washart, Ryan S. Soderquist in Nature Communications (2023)

  2. Article

    Open Access

    Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers

    Intrinsic resistance to anti-HER2 therapy in breast cancer remains an obstacle in the clinic, limiting its efficacy. However, the biological basis for intrinsic resistance is poorly understood. Here we perform...

    Yi Ding, Chang Gong, De Huang, Rui Chen, Pinpin Sui, Kevin H. Lin in Nature Communications (2018)

  3. Article

    Open Access

    Systematic map** of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity

    While inhibitors of BCL-2 family proteins (BH3 mimetics) have shown promise as anti-cancer agents, the various dependencies or co-dependencies of diverse cancers on BCL-2 genes remain poorly understood. Here w...

    Ryan S. Soderquist, Lorin Crawford, Esther Liu, Min Lu in Nature Communications (2018)

  4. Article

    Open Access

    Postnatal Development of the Murine Notochord Remnants Quantified by High-resolution Contrast-enhanced MicroCT

    The notochord gives rise to spinal segments during development, and it becomes embedded within the nucleus pulposus of the intervertebral disc (IVD) during maturation. The disruption of the notochord band has ...

    Sameer Bhalla, Kevin H. Lin, Simon Y. Tang in Scientific Reports (2017)

  5. Article

    Open Access

    Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia

    ABT-199, a potent and selective small-molecule antagonist of BCL-2, is being clinically vetted as pharmacotherapy for the treatment of acute myeloid leukemia (AML). However, given that prolonged monotherapy te...

    Kevin H. Lin, Peter S. Winter, Abigail **e, Cullen Roth in Scientific Reports (2016)

  6. Article

    Open Access

    Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers

    Molecular targeted drugs are clinically effective anti-cancer therapies. However, tumours treated with single agents usually develop resistance. Here we use colorectal cancer (CRC) as a model to study how the ...

    Sandra Misale, Ivana Bozic, **gshan Tong, Ashley Peraza-Penton in Nature Communications (2015)